Pulmonary large cell carcinoma with neuroendocrine morphology shows genetic similarity to large cell neuroendocrine carcinoma

• Published in: Diagnostic pathology 2022-02, Vol.17 (1), p.26-26, Article 26
• Main Authors: Liang, Zuoyu, Wang, Weiya, Hu, Qianrong, Zhou, Ping, Zhang, Ying, Tang, Yuan, Wu, Qian, Fu, Yiyun, Li, Xue, Shao, Yang, Jiang, Lili
• Format: Article
• Language: English
• Subjects: Analysis; Architecture; Cancer; Carcinoma; Carcinoma, Large Cell - metabolism; Carcinoma, Neuroendocrine - genetics; Carcinoma, Neuroendocrine - pathology; Classification; Cloning; Cytokeratin; Cytology; Cytoplasm; Genetic analysis; Genetic research; Histology; Humans; Immunohistochemistry; Large cell carcinoma; Large cell carcinoma with neuroendocrine morphology; Large cell neuroendocrine carcinoma; Lung carcinoma; Lung Neoplasms - pathology; Lymphatic system; Markers; Medical prognosis; Metastasis; Morphology; Mutation; Neuroendocrine tumors; p53 Protein; PD-L1 protein; Prognosis; Software; Subgroups; Survival analysis; TP53; Tumor proteins; Tumors
• ISSN: 1746-1596; 1746-1596
• DOI: 10.1186/s13000-022-01204-9

Large cell neuroendocrine carcinoma (LCNEC) is a high-grade malignant pulmonary neuroendocrine tumour. The distinction of pulmonary large cell carcinoma (LCC) and LCNEC is based on the presence of neuroendocrine morphology and the expression of at least one neuroendocrine marker in at least 10% of tumour cells in the latter. According to the current classification, LCC with neuroendocrine morphology and without neuroendocrine marker expression is classified as LCC. This subgroup we have named LCNEC-null and aimed to analyze its characteristics. 31 surgical samples resected in West China Hospital of Sichuan University between 2017 to 2021 were collected, including 7 traditional LCCs, 11 LCNEC-nulls and 13 LCNECs. Each case was conducted to immunohistochemistry and 425-panel-NGS. Compared to other LCCs, detailed analysis of LCNEC-nulls revealed biological features similar to those of LCNECs, especially for immunohistochemistry and molecular analysis: 1. diffusive, coarse granular and high expression of Pan-CK; 2. rare PD-L1 expression; 3. High rate of p53 expression and Rb deficiency 4. abundant genetic alterations are similar to LCNEC. All characteristics above deviated from traditional LCC, indicating they have the same origin as LCNEC. Furthermore, LCNEC could be genetically divided into two subtypes when we reclassified LCNEC-null as LCNEC, and the mutational type and prognosis differed significantly. We consider that LCNEC-null should be reclassified as LCNEC based on analysis above. In addition, two genetic types of LCNEC with different prognosis also indicate two mechanism of tumour formation.